Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-01-21 12:30 pm Purchase | 2025-12-31 | 13G | MBX Biosciences, Inc. Common Stock MBX | BlackRock Inc. BLK | 2,271,161 5.100% | 2,271,161 (New Position) | Filing History |
| 2025-11-14 4:05 pm Purchase | 2025-09-30 | 13G | MBX Biosciences, Inc. Common Stock MBX | P. Kent Hawryluk | 1,995,759 4.300% | 85,127 (+4.46%) | Filing History |
| 2025-11-12 6:44 pm Purchase | 2025-09-30 | 13G | MBX Biosciences, Inc. Common Stock MBX | Wellington Biomedical Innovation Master Investors (Cayman) II, L.P. | 2,017,394 4.500% | 227,272 (+12.70%) | Filing History |
| 2025-11-10 5:08 pm Purchase | 2025-11-06 | 13D | MBX Biosciences, Inc. Common Stock MBX | New Enterprise Associates 17, L.P. | 3,619,474 8.100% | 4,988 (+0.14%) | Filing History |
| 2025-10-06 12:22 pm Purchase | 2025-09-30 | 13G | MBX Biosciences, Inc. Common Stock MBX | Wellington Management Group LLP | 4,823,336 10.800% | 2,556,708 (+112.80%) | Filing History |
| 2025-09-30 7:06 pm Purchase | 2025-09-26 | 13D | MBX Biosciences, Inc. Common Stock MBX | ORBIMED ADVISORS LLC | 4,002,887 9.000% | 190,672 (+5.00%) | Filing History |
| 2025-09-30 6:15 pm Purchase | 2025-09-26 | 13D | MBX Biosciences, Inc. Common Stock MBX | Norwest Venture Partners XVI, LP | 2,140,989 4.800% | 4,654 (+0.22%) | Filing History |
| 2025-09-30 5:01 pm Purchase | 2025-09-26 | 13D | MBX Biosciences, Inc. Common Stock MBX | Frazier Life Sciences Public Fund, L.P. | 5,224,095 11.700% | 666,998 (+14.64%) | Filing History |
| 2025-08-20 5:23 pm Sale | 2025-08-18 | 13D | MBX Biosciences, Inc. Common Stock MBX | Frazier Life Sciences Public Fund, L.P. | 4,557,097 13.600% | -1,428,250 (-23.86%) | Filing History |
| 2025-08-14 08:48 am Sale | 2025-06-30 | 13G | MBX Biosciences, Inc. Common Stock MBX | Deep Track Capital, LP | 2,188,592 6.550% | -830,343 (-27.50%) | Filing History |
| 2025-08-12 10:34 am Sale | 2025-06-30 | 13G | MBX Biosciences, Inc. Common Stock MBX | Wellington Management Group LLP | 2,266,628 6.800% | -371,893 (-14.09%) | Filing History |
| 2025-05-12 10:44 am Sale | 2025-03-31 | 13G | MBX Biosciences, Inc. Common Stock MBX | Wellington Management Group LLP | 2,638,521 7.900% | -299,332 (-10.19%) | Filing History |
| 2024-11-08 10:52 am Purchase | 2024-09-30 | 13G | MBX Biosciences, Inc. Common Stock MBX | Wellington Management Group LLP | 2,937,853 9.220% | 2,937,853 (New Position) | Filing History |
| 2024-11-01 5:38 pm Purchase | 2024-09-30 | 13G | MBX Biosciences, Inc. Common Stock MBX | P. Kent Hawryluk | 1,910,632 5.550% | 1,910,632 (New Position) | Filing History |
| 2024-09-23 6:07 pm Purchase | 2024-09-16 | 13D | MBX Biosciences, Inc. Common Stock MBX | Norwest Venture Partners XVI, LP | 2,136,335 6.400% | 2,136,335 (New Position) | Filing History |
| 2024-09-23 6:05 pm Purchase | 2024-09-16 | 13D | MBX Biosciences, Inc. Common Stock MBX | New Enterprise Associates 17, L.P. | 3,614,486 11.400% | 3,614,486 (New Position) | Filing History |
| 2024-09-23 4:34 pm Purchase | 2024-09-16 | 13D | MBX Biosciences, Inc. Common Stock MBX | ORBIMED ADVISORS LLC | 3,812,215 12.000% | 3,812,215 (New Position) | Filing History |
| 2024-09-23 4:00 pm Purchase | 2024-09-13 | 13G | MBX Biosciences, Inc. Common Stock MBX | Deep Track Capital, LP | 3,018,935 9.480% | 3,018,935 (New Position) | Filing History |
| 2024-09-23 10:48 am Purchase | 2024-09-16 | 13D | MBX Biosciences, Inc. Common Stock MBX | Frazier Life Sciences Public Fund, L.P. | 5,985,347 18.800% | 5,985,347 (New Position) | Filing History |
| 2024-09-20 10:13 am Purchase | 2024-09-13 | 13G | MBX Biosciences, Inc. Common Stock MBX | Wellington Biomedical Innovation Master Investors (Cayman) II, L.P. | 1,790,122 5.620% | 1,790,122 (New Position) | Filing History |